Archives: Speakers

Cory Burke is the Executive Director Head of Biometrics and Data Management at Black Diamond Therapeutics. Cory has over 25 years of experience in the pharmaceutical industry in both CRO and Sponsor side. She has worked in many aspects of data management, database programming and SAS programming in the industry. She works collaboratively with Clinical Operations, Medical, Translational Medicine and many other cross functional teams. She has worked on a wide range of therapeutic areas (Oncology, Dermatology, Cardiology, Gastrologic,etc) from Phase I-IV.

Experienced Clinical Supply Chain Professional with holistic understanding of the pharmaceutical industry and GXP requirement for clinical trials, Phase I-IV, with extensive experience in managing and leading the end to end execution of clinical trials ensure effective and efficient supply of Investigational Product (IP) across the globe. Having collaborated with several clinical service providers and cross functional groups, Anu has exhaustive experience and unique insight on managing processes related to setting up and winding down of clinical trials.

Kevin Liao is Associate Director of Supply Chain at Caribou Biosciences where he is responsible for the planning and logistics of raw materials and delivering investigational allogeneic products to patients. He has more than a decade of experience in Supply Chain Planning, Logistics, Procurement, and Systems. Prior to Caribou, he was Head of Supply Chain and Procurement at insitro and Vor Biopharma building the Supply Chain functions and defining processes to support manufacturing and sourcing.

Well seasoned Quality Professional with a demonstrated history of working in the biotechnology industry. Strong quality assurance professional skilled in Quality Systems, CMC, QC, Regulatory, and overall GxP (GMP, GCP, GLP) Operations, including supplier oversight, investigations and CAPAs, change management, audits, vendor qualification, and Trial Master Files. Ability to navigate from Phase 1 up to and including commercialization.